Symptoms and Etiological Attribution: A Cross-Sectional Study in Mexican Outpatients with Psychosis and Their Relatives

• Published in: Schizophrenia Research and Treatment Vol. 2016; no. 2016; pp. 71 - 77
• Main Authors: Lizzette Gómez-de-Regil, Agnès Ros-Morente, Gisela Rodríguez-Hansen
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Limiteds 01.01.2016; Hindawi Publishing Corporation; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Care and treatment; Catatonia; Cross-sectional studies; Diagnosis; Etiology; Hallucinations; Mental disorders; Mental health; Middle school education; Middle schools; Patients; Personality; Psychoses; Psychosis; Schizophrenia; Social research; Mexico; Spain
• ISSN: 2090-2085; 2090-2093
• DOI: 10.1155/2016/9549683

This cross-sectional study aimed at identifying the most common attributions of their mental disorder in a Mexican patients who have experienced psychosis and their relatives and exploring how having experienced or not characteristic psychotic symptoms and their present clinical status might affect their etiological attributions. Past and current symptom profiles of 66 patients were as assessed with the SCID-I (Structured Clinical Interview for DSM-IV Axis I Disorders) and the PANSS (Positive and Negative Syndrome Scale), respectively. The etiological attribution of psychosis of patients ( n = 62 ) and the relatives ( n = 65 ) was assessed with the Angermeyer and Klusmann scale comprising 30 items into five categories: biology, personality, family, society, and esoteric. Patients and relatives attribute psychosis mainly to social factors. Relatives’ attributions were not influenced by clinical profile of patients, whereas in the case of patients it was only current clinical status that showed a difference, with those in nonremission scoring higher personality and family factors. Acknowledging patients’ and relatives’ beliefs about mental disorders at onset and later on is particularly important in psychosis, a mental condition with severe and/or persistent symptoms, in order to promote better involvement in treatment and in consequence efficacy and recovery.